Insider Holders & Insider Ownership - Syndax Pharmaceuticals Inc (SNDX)

List of insiders holdings for Syndax Pharmaceuticals Inc:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Domain Partners VI L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
10% Owner		2016-03-08 11:47:211,743,854
0		1,743,854Form 4
BVF PARTNERS L P
BIOTECHNOLOGY VALUE FUND L P
BIOTECHNOLOGY VALUE FUND II LP
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF INC
LAMPERT MARK N
10% Owner		2023-02-14 11:53:101,451,197
0		1,451,197Form 13G
Domain Partners VIII L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Halak Brian K
10% Owner		2021-01-20 19:57:091,162,554
0		1,162,554Form 13G
ROYSTON IVOR
Director		2017-03-22 13:37:240
625,545		625,545Form 4
Metzger Michael A
Chief Executive Officer		2024-02-09 16:05:03378,409
0		378,409Form 4
Sabus Steve M
Chief Commercial Officer		2022-12-05 16:41:39220,000
0		220,000Form 4
Podlesak Dennis
Director		2024-02-09 16:04:02141,763
0		141,763Form 4
Shaw Allan
Chief Financial Officer		2016-03-02 18:06:46137,600
0		137,600Form 3
Gallagher Neil
President, Head of R&D		2024-02-09 16:05:00117,188
0		117,188Form 4
Madigan Catherine
Chief Medical Officer		2023-02-03 17:01:12110,000
0		110,000Form 4
Karydas Daphne
Chief Financial Officer		2021-02-05 16:22:1995,000
0		95,000Form 4
Jarrett Jennifer
Director		2024-02-09 16:04:4965,000
0		65,000Form 4
Katkin Keith
Director		2024-02-09 16:04:3365,000
0		65,000Form 4
Meury William
Director		2024-02-09 16:04:1765,000
0		65,000Form 4
Legault Pierre
Director		2024-02-09 16:04:0065,000
0		65,000Form 4
Shea Richard P
Chief Financial Officer		2020-02-14 16:37:1753,227
0		53,227Form 4
Goldan Keith A.
Chief Financial Officer		2024-06-17 09:26:2752,623
0		52,623Form 4
Huber Martin H. Jr.
Director		2024-02-09 16:04:5149,000
0		49,000Form 4
Meyers Michael L.
SVP, Chief Medical Officer		2022-02-03 17:31:5342,344
0		42,344Form 4
Rizo Aleksandra
Director		2024-05-16 16:04:2535,000
0		35,000Form 4
Morrison Briggs
Director		2024-02-09 16:04:0834,836
0		34,836Form 4
Egros Fabrice
Director		2022-02-03 17:29:4432,000
0		32,000Form 4
Nolte Alexander
Chief Accounting Officer		2023-02-03 16:58:2417,000
0		17,000Form 4
Chen Henry
Director		2018-05-25 09:00:2514,000
0		14,000Form 4
EVNIN LUKE
Director
10% Owner		2018-05-25 09:00:1114,000
0		14,000Form 4
DP VI Associates L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Director
10% Owner		2016-03-08 11:52:2613,925
0		13,925Form 4
DOMAIN ASSOCIATES
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Halak Brian K
Kamdar Kim P.
Shah Nimesh
10% Owner		2016-03-02 18:37:2713,564
0		13,564Form 3
Kamdar Kim P.
Director
10% Owner		2016-11-02 16:44:508,000
0		8,000Form 4
DP VIII Associates L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
VITULLO NICOLE
Halak Brian K
10% Owner		2016-03-08 11:41:425,641
0		5,641Form 4
Sledge George W. Jr.
Director		2017-05-19 11:27:015,000
0		5,000Form 4
Ordentlich Peter
Chief Scientific Officer		2023-02-17 18:09:580
0		0Form 4
MPM BioVentures IV QP LP
Scopa James Paul
Foley Todd
GADICKE ANSBERT
KAILIAN VAUGHN M
MPM Asset Management Investors BV4 LLC
MPM BioVentures IV GmbH & Co. Beteiligungs KG
MPM BioVentures IV GP LLC
MPM BioVentures IV LLC
MPM BioVentures IV Strategic Fund L.P.
10% Owner		2021-02-12 16:06:570
0		0Form 13G